Your browser doesn't support javascript.
Is the second jab of an anti-SARS-CoV-2 vaccine reasonable after guillain-Barre syndrome following the first dose?
Finsterer, Josef.
  • Finsterer J; Department of Neurology, Neurology and Neurophysiology Center, Vienna, Austria.
Indian J Public Health ; 66(3): 385-386, 2022.
Article in English | MEDLINE | ID: covidwho-2055730

Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Indian J Public Health Year: 2022 Document Type: Article Affiliation country: Ijph.ijph_106_22

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Guillain-Barre Syndrome / COVID-19 Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Indian J Public Health Year: 2022 Document Type: Article Affiliation country: Ijph.ijph_106_22